PMGM

NASDAQ

Priveterra Acquisition Corp. II

SectorFinanceIndustryBlank ChecksIPO2021

News25/Ratings0

Priveterra Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with other businesses. The company was incorporated in 2020 and is based in Fort Lauderdale, Florida.

Latest news

25 items

707dSEC
SEC Form NT 10-Q filed by Priveterra Acquisition Corp. II
NT 10-Q - Priveterra Acquisition Corp. II (0001821606) (Filer)
720dPR
Priveterra Acquisition Corp. II Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
Priveterra Acquisition Corp. II (NASDAQ:PMGMU, PMGM, PMGMW))) (the "Company") today announced that on April 29, 2024, the Company received a notice (the "10-K Notice") from the staff of the Nasdaq Listing Qualifications department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") stating that, because the Company had not yet filed its Annual Report on Form 10-K for the period ended December 31, 2023 (the "Form 10-K"), the Company is not in compliance with Nasdaq Listing Rules for continued listing and, accordingly, such delinquency may serve as a separate basis for the delisting of the Company's securities from Nasdaq. The 10-K Notice also states that the Nasdaq Hearings Panel (the "P
720dNEWS
On April 29, Priveterra Acquisition Corp II Got Additional Notice From Nasdaq, Co Is No Longer In Compliance With Nasdaq Listing Rule 5250(c)(1)
- SEC Filing
720dSEC
Priveterra Acquisition Corp. II filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits
8-K - Priveterra Acquisition Corp. II (0001821606) (Filer)
751dSEC
SEC Form NT 10-K filed by Priveterra Acquisition Corp. II
NT 10-K - Priveterra Acquisition Corp. II (0001821606) (Filer)
797dSEC
Priveterra Acquisition Corp. II filed SEC Form 8-K: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
8-K - AEON Biopharma, Inc. (0001837607) (Filer)
799d13D/G
SEC Form SC 13G filed by Priveterra Acquisition Corp. II
SC 13G - AEON Biopharma, Inc. (0001837607) (Subject)
799d13D/G
SEC Form SC 13G/A filed by Priveterra Acquisition Corp. II (Amendment)
SC 13G/A - AEON Biopharma, Inc. (0001837607) (Subject)
883dSEC
SEC Form S-1/A filed by Priveterra Acquisition Corp. II (Amendment)
S-1/A - AEON Biopharma, Inc. (0001837607) (Filer)
892dSEC
SEC Form 10-Q filed by Priveterra Acquisition Corp. II
10-Q - AEON Biopharma, Inc. (0001837607) (Filer)
892dSEC
Priveterra Acquisition Corp. II filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - AEON Biopharma, Inc. (0001837607) (Filer)
916dSEC
SEC Form S-1/A filed by Priveterra Acquisition Corp. II (Amendment)
S-1/A - AEON Biopharma, Inc. (0001837607) (Filer)
917dSEC
Priveterra Acquisition Corp. II filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
8-K - AEON Biopharma, Inc. (0001837607) (Filer)
934dSEC
Priveterra Acquisition Corp. II filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
8-K - AEON Biopharma, Inc. (0001837607) (Filer)
975d13D/G
SEC Form SC 13D/A filed by Priveterra Acquisition Corp. (Amendment)
SC 13D/A - AEON Biopharma, Inc. (0001837607) (Subject)
975dSEC
SEC Form DEL AM filed by Priveterra Acquisition Corp.
DEL AM - AEON Biopharma, Inc. (0001837607) (Filer)
979dSEC
SEC Form S-1 filed by Priveterra Acquisition Corp.
S-1 - AEON Biopharma, Inc. (0001837607) (Filer)
981dINSIDER
SEC Form 4 filed by Thunen Shelley B
4 - AEON Biopharma, Inc. (0001837607) (Issuer)
981dINSIDER
SEC Form 4 filed by Palmisano Robert J
4 - AEON Biopharma, Inc. (0001837607) (Issuer)
981dINSIDER
SEC Form 4 filed by Fischer Jost
4 - AEON Biopharma, Inc. (0001837607) (Issuer)
981dINSIDER
SEC Form 4 filed by Carter Eric G
4 - AEON Biopharma, Inc. (0001837607) (Issuer)
983dINSIDER
SEC Form 4: Strathspey Crown Holdings Group, Llc sold $73,803,940 worth of shares (7,380,394 units at $10.00), decreasing direct ownership by 78% to 2,031,773 units
4 - AEON Biopharma, Inc. (0001837607) (Issuer)
986dSEC
Priveterra Acquisition Corp. filed SEC Form 8-K: Financial Statements and Exhibits (Amendment)
8-K/A - AEON Biopharma, Inc. (0001837607) (Filer)
997dINSIDER
SEC Form 3: New insider Strathspey Crown Holdings Group, Llc claimed ownership of 9,420,370 shares
3 - AEON Biopharma, Inc. (0001837607) (Issuer)
997d13D/G
SEC Form SC 13D filed by Priveterra Acquisition Corp.
SC 13D - AEON Biopharma, Inc. (0001837607) (Subject)